scispace - formally typeset
F

François Paye

Researcher at University of Paris

Publications -  138
Citations -  6880

François Paye is an academic researcher from University of Paris. The author has contributed to research in topics: Survival rate & Pancreas. The author has an hindex of 40, co-authored 137 publications receiving 5734 citations. Previous affiliations of François Paye include French Institute of Health and Medical Research & Pierre-and-Marie-Curie University.

Papers
More filters
Journal ArticleDOI

European evidence-based guidelines on pancreatic cystic neoplasms

Marco Del Chiaro, +88 more
- 01 May 2018 - 
TL;DR: A conservative approach is recommended for asymptomatic MCN and IPMN, and Lifelong follow-up of IPMN is recommended in patients who are fit for surgery.
Journal ArticleDOI

Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.

TL;DR: IMPT of the branch type occurs in younger patients and is associated with less aggressive histologic features than is the main pancreatic duct type, which raises the difficult issue of clinical management of IPMT of the branches type as a distinctive group.
Journal ArticleDOI

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

TL;DR: The GEMOX combination is active and well tolerated in ABTA and should be used as first-line chemotherapy in advanced biliary tract adenocarcinoma patients.
Journal ArticleDOI

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma

TL;DR: Overall five year survival rate was higher in patients with resected in situ/invasive stage I malignant IPMT compared with those with pancreatic ductal carcinoma, but was similar in the subset of stage II/III tumours.
Journal ArticleDOI

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

TL;DR: Using sequencing and gene expression analyses, a subgroup of HCA is identified by fusion of the INHBE and GLI1 genes and activation of sonic hedgehog pathway associated with malignant transformation and bleeding, respectively.